Medicinova Inc
MNOV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001226616
In the last 90 days, Medicinova Inc insiders filed 0 open-market purchases and 1 sale; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Medicinova Inc changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 30 | 29 | −1 |
| Shares | 5.40M | 5.18M | −226.4K (−4.2%) |
| Value | $7.40M | $6.84M | −$568.7K (−7.7%) |
New holders (3)
Institutions that held Medicinova Inc at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Buckingham Strategic Partners | 10,000 | $13.2K | 0.00% |
| Larson Financial Group LLC | 5 | $7 | 0.00% |
| Caitong International Asset Management Co., Ltd | 2 | $3 | 0.00% |
Sold out (4)
Institutions that held Medicinova Inc at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Goldman Sachs Group Inc | 27,824 | $38.1K |
| JPMorgan Chase & Co | 20,576 | $28.0K |
| XTX Topco Ltd | 14,117 | $19.3K |
| Banque Transatlantique SA | 1,850 | $2.62K |